PAR 2.38% 20.5¢ paradigm biopharmaceuticals limited..

Yeah, of course, but the idea behind writing-in contingencies on...

  1. 1,783 Posts.
    lightbulb Created with Sketch. 1969
    Yeah, of course, but the idea behind writing-in contingencies on a contract is that the described deal only goes ahead if the specified parameters are met. Therefore, in your scenario, the partner entity are not liable for the proposed $30m until the specific hurdle (e.g. 2x2) is clear. My company has contingencies in just about all our supplier contracts. Basically, they are in-principle deals which only become formalised when a specified milestone is reached. It can end up benefiting both sides. In PAR's case, this could immediately re-invite optimism and lift the share-price if a CR is needed to bridge the gap, it may even assist in securing a credit-agreement / debt-funding, again to bridge the gap until the trials are green-lit because that is the trigger for up-front payment. This all feels better to me than being forced to CR while the company is in it's current circumstance of open-ended waiting time and dwindling cash position.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
-0.005(2.38%)
Mkt cap ! $71.73M
Open High Low Value Volume
20.0¢ 21.0¢ 20.0¢ $152.8K 744.7K

Buyers (Bids)

No. Vol. Price($)
3 78174 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 84426 5
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.